|Mr. Robert Abenante||Pres, CEO & Director||N/A||N/A||N/A|
|Mr. Douglas J. Sorocco LLB||Advisor||N/A||N/A||1971|
|Mr. Guy P. Dancosse||Advisor||N/A||N/A||1944|
|Mr. Francesco Paolini||CFO & Director||N/A||N/A||N/A|
|Mr. Patrick Mitchell||COO & Director||N/A||N/A||N/A|
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also offers Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Abattis Bioceuticals Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.